Showing results (171-180 of 644) with videos related to
Sort By:
Pageof 65
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 7, 2009
Prooxidant action of chebulinic acid and tellimagrandin I: causing copper-dependent DNA strand breaksZong-Chun Yi, Yan-Ze Liu, Hai-Xia Li, et al.Natural Product Communications|July 17, 2014
Induced production of new diterpenoids in the fungus Penicillium funiculosumDong-Ze Liu, Bo-Wen Liang, Xiao-Fei Li, et al.Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases|March 3, 2015
[An overview on the physiological and ecological adaptation mechanisms of the overwinter ticks]Zhi-jun Yu, Xiao-long Yang, Jie Chen, et al.Clinical and Experimental Medicine|March 19, 2025
Analysis of the effectiveness and safety of lenvatinib/bevacizumab combined with PD-1/PD-L1 inhibitors and GEMOX in the first-line treatment of advanced biliary tract carcinomaLu Zhao, Zhengfeng Zhang, Dazhen Wang, et al.Frontiers in Neurology|January 5, 2026
Methylprednisolone pulse versus docetaxel in recurrent thymoma with myasthenia gravisHongxia Yang, Yaxuan Wang, Zulin Pan, et al.ACS Applied Materials & Interfaces|July 2, 2021
Computational Prediction of Superlubric Layered HeterojunctionsEnlai Gao, Bozhao Wu, Yelingyi Wang, et al.American Journal of Translational Research|May 16, 2023
Bibliometric and visual analysis of trends in tenosynovitis research from 1999 to 2021Ze Liu, Qi Liu, Hongbin Guo, et al.International Journal of Environmental Research and Public Health|March 29, 2023
Effect of High-Intensity Interval Training vs. Moderate-Intensity Continuous Training on Fat Loss and Cardiorespiratory Fitness in the Young and Middle-Aged a Systematic Review and Meta-AnalysisZhicheng Guo, Meng Li, Jianguang Cai, et al.BMC Public Health|December 10, 2025
A socioecological model of multilevel determinants for proactive health behaviors among Chinese adults with chronic diseasesChaoyi Chen, Yanhua Hao, Weilan Xu, et al.Journal of Hepatocellular Carcinoma|June 24, 2024
PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective StudyDazhen Wang, Zhengfeng Zhang, Liu Yang, et al.Pageof 65